Recently Featured

FDA Launches AI Nutrition Tool Grok Amid Concerns Over New Food Guidelines

February 15, 2026
The U.S. Food and Drug Administration (FDA) has introduced Grok, a generative AI tool designed to provide users with insights into the new food pyramid, which has garnered mixed reviews from nutrition experts. Kyle Diamantas, head of the Human Foods Program at the FDA, announced the tool on the government’s realfood.gov site, emphasizing its capability…

Study Links Gut Bacteria to ALS and Dementia Through Inflammatory Glycogen

February 15, 2026
In a new study published in Cell Reports titled, “9orf72 in myeloid cells prevents an inflammatory response to microbial glycogen,” researchers from Case Western Reserve University have identified a link between gut bacteria and the deterioration of the brain in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Results identified bacterial sugars that cause neurodegenerative…

Long COVID-Linked Brain Changes May Signal Alzheimer’s Disease Risk

February 15, 2026
A study led by NYU Langone Health researchers reveals that patients suffering from long COVID exhibit significant alterations in the choroid plexus (ChP), a brain structure associated with Alzheimer’s disease (AD). The findings indicate that these patients have a 10% larger ChP and reduced blood flow, correlating with known blood markers of AD and cognitive…

ILiAD Biotechnologies Secures $115 Million to Advance Whooping Cough Vaccine

February 14, 2026
ILiAD Biotechnologies has successfully raised $115 million in an oversubscribed Series B financing round, a significant boost for its efforts to advance a whooping cough vaccine into pivotal Phase 3 clinical trials. This funding comes at a critical juncture for the vaccine industry, which has faced numerous challenges in recent years, including public hesitancy and…

Ongoing Cases